Traynor Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Traynor Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Sell	5,533 -2,007	-27%	-$115K	0.01%	246
2026 Q1	$450K	Buy	7,540 +2,034	+37%	+$119K	0.03%	189
2025 Q4	$297K	Sell	5,506 -490	-8%	-$23.6K	0.02%	252
2025 Q3	$270K	Sell	5,996 -2,972	-33%	-$139K	0.02%	260
2025 Q2	$426K	Buy	8,968 +2,829	+46%	+$139K	0.03%	149
2025 Q1	$374K	Sell	6,139 -1,136	-16%	-$66.2K	0.03%	142
2024 Q4	$411K	Buy	7,275 +300	+4%	+$16.8K	0.03%	165
2024 Q3	$361K	Buy	6,975 +669	+11%	+$31.4K	0.02%	167
2024 Q2	$262K	Sell	6,306 -1,366	-18%	-$61.1K	0.02%	188
2024 Q1	$416K	Buy	7,672 +207	+3%	+$10.5K	0.04%	158
2023 Q4	$383K	Sell	7,465 -470	-6%	-$24.7K	0.04%	153
2023 Q3	$461K	Sell	7,935 -2,702	-25%	-$166K	0.06%	131
2023 Q2	$680K	Sell	10,637 -336	-3%	-$22.5K	0.08%	107
2023 Q1	$761K	Sell	10,973 -173	-2%	-$12.2K	0.11%	96
2022 Q4	$802K	Buy	11,146 +315	+3%	+$23.8K	0.11%	98
2022 Q3	$769K	Buy	10,831 +124	+1%	+$8.99K	0.14%	75
2022 Q2	$824K	Sell	10,707 -560	-5%	-$42.6K	0.14%	74
2022 Q1	$822K	Sell	11,267 -433	-4%	-$29.1K	0.11%	87
2021 Q4	$729K	Sell	11,700 -2,325	-17%	-$136K	0.09%	107
2021 Q3	$829K	Buy	14,025 +1,229	+10%	+$80.9K	0.11%	95
2021 Q2	$856K	Sell	12,796 -505	-4%	-$32.9K	0.12%	90
2021 Q1	$839K	Buy	13,301 +4,016	+43%	+$250K	0.14%	80
2020 Q4	$575K	Sell	9,285 -2,437	-21%	-$150K	0.1%	92
2020 Q3	$704K	Sell	11,722 -771	-6%	-$46.4K	0.16%	78
2020 Q2	$734K	Buy	12,493 +189	+2%	+$11.3K	0.18%	67
2020 Q1	$685K	Sell	12,304 -737	-6%	-$45K	0.24%	59
2019 Q4	$837K	Buy	13,041 +7,337	+129%	+$420K	0.22%	80
2019 Q3	$289K	Buy	5,704 +4	+0.1%	+$188	0.09%	126
2019 Q2	$263K	Sell	5,700 -3,610	-39%	-$168K	0.09%	135
2019 Q1	$444K	Buy	9,310 +2,729	+41%	+$136K	0.15%	98
2018 Q4	$342K	Buy	6,581 +978	+17%	+$52.5K	0.14%	98
2018 Q3	$347K	Buy	5,603 +3	+0.1%	+$178	0.11%	117
2018 Q2	$309K	Buy	5,600 +3	+0.1%	+$162	0.11%	124
2018 Q1	$354K	Buy	5,597 +2	+0%	+$129	0.14%	103
2017 Q4	$342K	Buy	5,595 +3	+0.1%	+$188	0.15%	109
2017 Q3	$352K	Sell	5,592 -1,320	-19%	-$77.1K	0.17%	112
2017 Q2	$374K	Buy	6,912 +64	+0.9%	+$3.48K	0.18%	105
2017 Q1	$383K	Buy	6,848 +766	+13%	+$42K	0.21%	93
2016 Q4	$296K	Buy	6,082 +6	+0.1%	+$328	0.2%	96
2016 Q3	$303K	Buy	6,076 +5	+0.1%	+$321	0.21%	94
2016 Q2	$447K	Buy	6,071 +4	+0.1%	+$283	0.35%	64
2016 Q1	$387K	Sell	6,067 -3,862	-39%	-$244K	0.31%	70
2015 Q4	$683K	Sell	9,929 -531	-5%	-$35.1K	0.49%	47
2015 Q3	$619K	Buy	10,460 +5	+0%	+$317	0.53%	42
2015 Q2	$695K	Buy	10,455 +5,452	+109%	+$359K	0.58%	38
2015 Q1	$322K	Buy	5,003 +3	+0.1%	+$188	0.31%	71
2014 Q4	$295K	Buy	+5,000	New	+$282K	0.34%	72

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Traynor Capital Management's BMY Position: Q2 2026 in Review

Traynor Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 27% in Q2 2026, selling an estimated $115K and leaving 5,533 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #246.

Traynor Capital Management first reported a position in BMY in Q4 2014 and has held it in 47 quarters since. The position peaked at $856K in Q2 2021. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Traynor Capital Management held 5,533 shares of Bristol-Myers Squibb worth $319K as of Q2 2026.
Traynor Capital Management sold 2,007 Bristol-Myers Squibb shares in Q2 2026, an estimated $115K.
Bristol-Myers Squibb made up 0.01% of Traynor Capital Management's portfolio in Q2 2026, its #246 holding.
Traynor Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 47 quarters since.
Traynor Capital Management's Bristol-Myers Squibb position peaked at $856K in Q2 2021.
879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.